Format

Send to

Choose Destination
J Obstet Gynaecol Res. 2013 Jun;39(6):1147-52. doi: 10.1111/jog.12042. Epub 2013 May 30.

Glyburide as treatment option for gestational diabetes mellitus.

Author information

1
Obstetrics and Gynaecology Department, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India.

Abstract

AIM:

The aim of this study was to assess the efficacy of glyburide in the treatment of gestational diabetes mellitus and to compare the maternal and fetal outcome between two groups treated either with insulin or glyburide.

MATERIAL AND METHODS:

Women with gestational diabetes not responding to diet control were randomized into two groups: (i) the control group receiving insulin (n = 32); and (ii) the study group receiving glyburide (n = 32). Primary outcome was assessed in terms of achievement of glycemic control and secondary outcome was assessed by the incidence of maternal and fetal complications in the insulin and glyburide treated groups.

RESULTS:

The achievement of glycemic control between the insulin and the glyburide treated groups showed no significant difference (97.1%, 93.8%). The occurrence of maternal complications (P = 0.87) and fetal complications (P = 0.32) were comparable between the insulin and glyburide treated groups.

CONCLUSION:

Glyburide was found to be as efficacious as insulin in achieving euglycemia in the treatment of gestational diabetic women who require treatment beyond diet control.

PMID:
23718748
DOI:
10.1111/jog.12042
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center